Simultaneous Monitoring of Cell-surface Receptor and Tumor-targeted Photodynamic Therapy via TdT-initiated Poly-G-Quadruplexes
Shi T, Wang M, Li H, Wang M, Luo X, Huang Y, Wang HH, Nie Z, Yao S. Sci Rep. 2018 Apr 3;8(1):5551. PubMed
Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer
Powell Gray B, Kelly L, Ahrens DP, Barry AP, Kratschmer C, Levy M, Sullenger BA. Proc Natl Acad Sci U S A. 2018 Apr 16. pii: 201717705. PubMed
Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers
Philippou S, Mastroyiannopoulos NP, Makrides N, Lederer CW, Kleanthous M, Phylactou LA. MolTher Nucleic Acids. 2018 Mar 2;10:199-214. PubMed
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Esposito CL, Nuzzo S, Catuogno S, Romano S, de Nigris F, de Franciscis V. MolTher Nucleic Acids. 2018 Mar 2;10:398-411. PubMed
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
Yu X, Ghamande S, Liu H, Xue L, Zhao S, Tan W, Zhao L, Tang SC, Wu D, Korkaya H, MolTher Nucleic Acids. 2018 Mar 2;10:317-330. PubMed
A DNA thioaptamer with homing specificity to lymphoma bone marrow involvement
Mai J, Li X, Zhang G, Huang Y, Xu R, Shen Q, Lokesh GLR, Thiviyanathan V, Chen L, Liu H, Zu Y, Ma X, Volk DE, Gorenstein DG, Ferrari M, Shen H. Mol Pharm. 2018 Mar 14. PubMed
Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers
Liu Z, Chen T, Romesberg FE. Chem Sci. 2017 Dec 1;8(12):8179-8182. PubMed
Supramolecular aptamer nano-constructs for receptor-mediated targeting and light-triggered release of chemotherapeutics into cancer cells
Prusty DK, Adam V, Zadegan RM, Irsen S, Famulok M. Nat Commun. 2018 Feb 7;9(1):535. PubMed
RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice
Taguchi K, Yamagishi SI, Yokoro M, Ito S, Kodama G, Kaida Y, Nakayama Y, Ando R, Yamada-Obara N, Asanuma K, Matsui T, Higashimoto Y, Brooks CR, Ueda S, Okuda S, Fukami K. Sci Rep. 2018 Feb 8;8(1):2686. PubMed
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Li S, Jiang Q, Liu S, Zhang Y, Tian Y, Song C, Wang J, Zou Y, Anderson GJ, Han JY, Chang Y, Liu Y, Zhang C, Chen L, Zhou G, Nie G, Yan H, Ding B, Zhao Y. Nat Biotechnol. 2018 Feb 12. PubMed